Calcifediol Is Not Superior to Cholecalciferol in Improving Vitamin D Status in Postmenopausal Women
J Bone Miner Res
.
2022 Jul;37(7):1411-1412.
doi: 10.1002/jbmr.4560.
Epub 2022 May 6.
Authors
Manuel Sosa-Henríquez
1
2
,
M A Jesús Gómez de Tejada-Romero
3
,
M A Jesús Cancelo-Hidalgo
4
,
Guillermo Martínez Díaz-Guerra
5
,
Íñigo Etxebarría Foronda
6
,
Francisco José Tarazona-Santabalbina
7
,
Óscar Torregrosa-Suau
8
,
Carmen Valdés-Llorca
9
Affiliations
1
University of Las Palmas de Gran Canaria, Investigation Group on Osteoporosis and Bone and Mineral Diseases, Las Palmas de Gran Canaria, Spain.
2
Bone Metabolic Unit, Hospital University Insular, Las Palmas de Gran Canaria, Spain.
3
Department of Medicine, University of Seville, Seville, Spain.
4
University Hospital of Guadalajara, Alcalá University, Madrid, Spain.
5
University Hospital 12 de Octubre. Madrid, University Complutense, Madrid, Spain.
6
Department of Orthopaedic, Alto Deba Hospital, Mondragon, Spain.
7
Geriatric Service, University Hospital La Ribera, Alzira, Spain.
8
Bone Metabolic Unit. Service of Internal Medicine, University General Hospital, Elche, Spain.
9
Health Center of Fuencarral. SERMAS, Madrid, Spain.
PMID:
35451531
PMCID:
PMC9545200
DOI:
10.1002/jbmr.4560
No abstract available
Publication types
Letter
Comment
MeSH terms
Calcifediol
Cholecalciferol
Dietary Supplements
Female
Humans
Osteoporosis, Postmenopausal*
Postmenopause
Vitamin D
Vitamin D Deficiency* / drug therapy
Substances
Vitamin D
Cholecalciferol
Calcifediol